Smith, Aaron G <br/><br/>
PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells.  [electronic resource] 

 -  The international journal of biochemistry & cell biology  Apr 2009 
 - 844-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-5875 
<br/><br/><label>Standard No.: </label>10.1016/j.biocel.2008.08.037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>COS Cells<br/>Cell Cycle--drug effects<br/>Cell Growth Processes--drug effects<br/>Cell Line, Tumor<br/>Chlorocebus aethiops<br/>Chromans--pharmacology<br/>Halofenate--pharmacology<br/>Humans<br/>Melanoma--drug therapy<br/>PPAR gamma--agonists<br/>RNA, Messenger--biosynthesis<br/>RNA, Small Interfering--genetics<br/>Rosiglitazone<br/>Signal Transduction--drug effects<br/>Thiazolidinediones--pharmacology<br/>Troglitazone<br/>Wnt Proteins--agonists<br/>beta Catenin--genetics